May 15–17, 2021, Virtual

Amgen is proud to be a part of the American College of Cardiology's 70th Annual Scientific Session & Expo. While you're here, you can explore the latest scientific information and disease state education from Amgen, and learn about Amgen's long-term commitment to developing and delivering transformative medicines for patients with cardiovascular disease.

Amgen | A Worldwide Pioneer in Biotechnology

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit and follow us on